{"name":"Green Signal Biopharma Private Limited","slug":"green-signal-biopharma-private-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BCG Vaccine IP - Serum Institute of India","genericName":"BCG Vaccine IP - Serum Institute of India","slug":"bcg-vaccine-ip-serum-institute-of-india","indication":"Tuberculosis prevention in infants and high-risk populations","status":"phase_3"}]}],"pipeline":[{"name":"BCG Vaccine IP - Serum Institute of India","genericName":"BCG Vaccine IP - Serum Institute of India","slug":"bcg-vaccine-ip-serum-institute-of-india","phase":"phase_3","mechanism":"BCG vaccine stimulates the immune system to recognize and attack tuberculosis-causing bacteria through activation of T-cells and macrophages.","indications":["Tuberculosis prevention in infants and high-risk populations","Potential immunotherapeutic use in bladder cancer (investigational)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKQjVRa3Fjay05WEdjelFUYkNVdVQ5VFFPYk42eGRvLXpTOVJYdHJaTjY4RjE3VHlmOWM0SDV1QmZKNEJXTmg0YVd2eEptbllhaklWQy1vRWdwNC1aUmptb1BfdGZLUQ?oc=5","date":"2026-01-05","type":"regulatory","source":"Fierce Pharma","summary":"2025 drug approvals: Despite FDA tumult and macro uncertainty, biopharma scored with 55 new products - Fierce Pharma","headline":"2025 drug approvals: Despite FDA tumult and macro uncertainty, biopharma scored with 55 new products","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVUZCQ2pBbHRXVXdJOXdXODkxYWpQbmw3NmlhZGRYWlJiQkZRTjZLeFJHTHNKaGlFR3ZPNWRxOHhpVzNmemdmMV9YenkyZDB0N0NGSW9yTkVidnI4WDJGUTJieHhhODZENzJTTXdEeGtnNmR6dGhNMnRTbnhCcGt2UUw0dVB4YnAxUnZhWFNpdw?oc=5","date":"2025-03-24","type":"regulatory","source":"BioPharma Dive","summary":"Verve gets FDA green light to expand base editing trial into US - BioPharma Dive","headline":"Verve gets FDA green light to expand base editing trial into US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOdVJ6SjhOMlRHZ0xHd1VfWEhIdGQtZkNteHFCbjJVQ3poaERfekxUV3pGLTNnbzdUWHhXX3VVSktDemVkSHZlNUllSC1FMWxPdzA4SDE1eGlfaHZ5QnRxS0JFN3Rhc2VLdmQzdmxhOXRCS2xwWUl0aVNRTllqTkdSNHdQdjRBdVk?oc=5","date":"2025-03-13","type":"regulatory","source":"pharmaphorum","summary":"Kelun-Biotech first to bag TROP2 approval in lung cancer - pharmaphorum","headline":"Kelun-Biotech first to bag TROP2 approval in lung cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOLUd3a0VqSWNncm01VkdTelJxdXNuNTJyOHBId3FNWkM4dXdjWVhzY2dyZHB5cVlpUmZUSDlmOHVCZTQ3WnRtOFNwWjNNX0lDVDlVTGhGdXVMZkRxQ0lRUFhodURvSnBmV1FTZjllTFR3bDZCLTJxaEw4NS1PWW1ZSkFFRGdkVnhxWWZKNXNMSGk?oc=5","date":"2025-01-12","type":"pipeline","source":"BioPharma Dive","summary":"Tune raises $175M for hepatitis B medicine, epigenetic research - BioPharma Dive","headline":"Tune raises $175M for hepatitis B medicine, epigenetic research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOMHlhMWt6eU9ScUoxRzVWSkwwQTVhcnhCVGVhMkdYR29iYzBOMFJhcVI0eU5Vei03eURucGZvSjNRcGc3SjdmbmRhcFUwbXBzMnJ3Mmp1Mmk0M0pNaFFjRlQ4bi1MNmk3cHRLUWdFYk5rU0dCZGhKM242NlU1dFVGd0dqSDVudnBXRTczRDYzQUJITVdIa0FOd3pXOU8yRDdPR1EyNWlGQQ?oc=5","date":"2024-08-26","type":"deal","source":"Green Queen Media","summary":"Zydus to Buy 50% of Perfect Day's Stake in Sterling Biotech & Open Animal-Free Protein Factory - Green Queen Media","headline":"Zydus to Buy 50% of Perfect Day's Stake in Sterling Biotech & Open Animal-Free Protein Factory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQenM2QzNoclJMVHpzWFgyTmZDZ1hFcG1lYUp6Uk5LSFJ3RFpVODQ0Z19JLUJCR292ZDlZaWlKc2pQVEozM203YnNWREdoMEpacHUycmlzZHhGV3hBVFRQY25vRzg0dFF6Y3RxRmxXc2I2SWQtS2FvZXhpV3ZMbDZ6MG5SX2JVN3gxTkZUSURsRFNMRmVDbGpZSWV1YnRfOUx2UGpYcnpuZmdYQjBzZnYySDUwNWtWZ3o4MUE?oc=5","date":"2021-01-22","type":"regulatory","source":"The Globe and Mail","summary":"‘Monumental’ moment for Canadian biotech as B.C.’s Aurinia gets FDA green light to sell new lupus drug - The Globe and Mail","headline":"‘Monumental’ moment for Canadian biotech as B.C.’s Aurinia gets FDA green light to sell new lupus drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOUFFDWk83YmtPZDE2c1NDeVR6dFh4bnBWMGFBTlNsS3pHYkY1dVRWdWpSTWdBamFydlIxdk9BQk1DWE9KTXAwQ3VOTjR1eGw5bGhOdENEQVlwa3FIdWlHckFsMWQ4UXpJeUgxQ29VSWFyeTJQUDNJcFl5OTMtaHQ2N25BMHBDUlJmU01qOVZOanQ3MWlJeERYOUJLRUtUTkVPWkpWSzZ3WExHVVBQSmRvaUk4MllHNHdJSDFzT3V6Z0NVaFhGMVk2MDZoLVdSTTM4dGNYOUl0Ui1xTGZmSlllRUtEODBBVDNKTW8xS1ZhTlZwR2s3UDY0R2ZCaGd2WFRXbmRaTTFBaVd2b09uVXo0MDF4RUlhcmd1?oc=5","date":"2014-05-14","type":"deal","source":"The Economic Times","summary":"Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio Chemicals - The Economic Times","headline":"Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio Chemicals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2013-06-14","type":"pipeline","source":"Business Standard","summary":"Tatas mull entry into biotech, drug R&D - Business Standard","headline":"Tatas mull entry into biotech, drug R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiOkFVX3lxTE9xUnktMklHVURZci1jbkxlOUlJWXAwd0JFLXItcENtRDJlM3dINVJVZkV0S3BmeFVwcGc?oc=5","date":"2006-03-15","type":"pipeline","source":"Merck","summary":"Merck | Home - Merck","headline":"Merck | Home","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}